Study suggests anti-amyloid treatment may halve
Author: Michael
Human Longevity Inc (HLI), a precision health int
Elevant’s best-selling biohacking product prov
Company to initiate clinical study of gene-silen
Sens.
Portuguese defender invests more than €1 milli
Longevity startup offers AI-powered blood biomar
Retro Biosciences has unveiled three therapeutic
New research finds that endothelial TDP-43 loss
Progress in spinal cord injury lays the foundati